14 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in May 2029. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
4
Ending by 2030
May 2029
Next term end
6
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2040 · High confidence
Also notable
Ends Jun 2038 · High confidence
Also notable
Ends Jun 2038 · High confidence
Novel Gene Classifiers and Uses Thereof in Skin Cancers
US 11,578,373
Cited by 10 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2040.
Dermatology Report Document
US D989,861
The newest of the three, granted 2023. It anchors the portfolio to 2038, later than anything else here.
Dermatology Report Document
US D988,399
The newest of the three, granted 2023. It anchors the portfolio to 2038, later than anything else here.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 16, 2026The maintenance fee for Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis (US 9,057,109) comes due Dec 16, 2026. Unpaid by Jun 16, 2027, it lapses early.
- 2 fees due Mar 10 to 12, 2027 · next Mar 10
- 1 fee due Nov 7, 2027The maintenance fee for Novel Gene Classifiers and Uses Thereof in Non-Melanoma Skin Cancers (US 11,976,332) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 1 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis | 9 in force | to Aug 2041 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,057,109 | Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis In force · Medium confidence | In force | Medium confidence | |
| US 11,332,795 | Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis In force · Medium confidence | In force | Medium confidence | |
| US 11,753,687 | Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis In force · Medium confidence | In force | Medium confidence | |
| US 10,407,729 | Diagnosis of Melanoma by Nucleic Acid Analysis In force · Medium confidence | In force | Medium confidence | |
| US 10,709,428 | Non-Invasive Skin Collection System In force · High confidence | In force | High confidence | |
| US D966,299 | Computer Display Panel with a Graphical User Interface for a Dermatology Report In force · High confidence | In force | High confidence | |
| US D966,300 | Computer Display Panel with a Graphical User Interface for a Dermatology Report In force · High confidence | In force | High confidence | |
| US D988,399 | Dermatology Report Document In force · High confidence | In force | High confidence | |
| US D989,861 | Dermatology Report Document In force · High confidence | In force | High confidence | |
| US 11,643,689 | Methods for Diagnosing Atopic Dermatitis Using Gene Classifiers In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 14: 4 patents ended · 8 applications pending · 31 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.